Clincosm LogoSign in Get a demo

adjuvant therapy

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023

NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Befotertinib + Icotinib placebo
  • Icotinib + Befotertinib placebo
  • Beijing, China
  • +2 more
Sep 20, 2023

Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Recruiting
  • Breast Cancer
  • +2 more
    • Bouge, Belgium
      Clinique Saint-Luc Bouge
    Oct 25, 2022

    MSI-H, PD-1 Immunotherapy, Gastric Cancer Trial in Shanghai (SOX, XELOX, Observation)

    Not yet recruiting
    • MSI-H
    • +3 more
    • Shanghai, China
      Dazhi Xu
    Jul 20, 2022

    Hepatocellular Carcinoma, Adjuvant Therapy Trial in Changsha (TQB2450 injection, Anlotinib HCl capsules)

    Recruiting
    • Hepatocellular Carcinoma
    • Adjuvant Therapy
    • TQB2450 injection
    • Anlotinib hydrochloride capsules
    • Changsha, Hunan, China
      Hunan Provincial People's Hospital (The First Affiliated Hospita
    Apr 28, 2022

    Prognosis of Low-grade Endometrial Stromal Sarcoma

    Recruiting
    • Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis)
    • +6 more
    • Surgical treatment with and without fertility-sparing procedures
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    Breast Cancer, Adjuvant Therapy Trial in Fuzhou (Pyrotinib+Trastuzumab+Capecitabine, Trastuzumab+Pertuzumab/Trastuzumab)

    Recruiting
    • Breast Cancer
    • Adjuvant Therapy
    • Fuzhou, Fujian, China
      Fujian Medical University Union Hospital
    Mar 14, 2022

    HER2-positive Breast Cancer, Adjuvant Therapy Trial in Hangzhou (Paclitaxel, Trastuzumab, Docetaxel)

    Recruiting
    • HER2-positive Breast Cancer
    • Adjuvant Therapy
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 26, 2021

    ALK Fusion Protein Expression, Adjuvant Therapy, NSCLC Trial (Ensatinib, chemo)

    Not yet recruiting
    • ALK Fusion Protein Expression
    • +2 more
    • (no location specified)
    Jan 10, 2022

    Hepatocellular Carcinoma, Adjuvant Therapy Trial in Hangzhou (Tislelizumab, TACE)

    Recruiting
    • Hepatocellular Carcinoma
    • Adjuvant Therapy
    • Hangzhou, Zhejiang, China
      the First Affiliated Hospital, School of Medicine, Zhejiang Univ
    Jan 4, 2022

    Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

    Recruiting
    • Stomach Neoplasms
    • +7 more
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 3, 2021

    Colon Cancer, Adjuvant Therapy Trial in Netherlands (Acetylsalicylic acid, Placebo Acetylsalicylic acid)

    Recruiting
    • Colon Cancer
    • Adjuvant Therapy
    • Acetylsalicylic acid
    • Placebo Acetylsalicylic acid
    • Almelo, Netherlands
    • +31 more
    Sep 22, 2021

    Immunotherapy, Adjuvant Therapy, Colon Cancer Trial in Tianjin (Tirelizumab)

    Recruiting
    • Immunotherapy
    • +3 more
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 11, 2021

    Adjuvant Therapy for Stage II-III Colon Cancer After Radical

    Recruiting
    • Stage II Colon Cancer
    • +2 more
      • Nanjing, Jiangsu, China
      • +2 more
      Jul 14, 2021

      HCC, Adjuvant Therapy, Immunotherapy Trial in Guangzhou (Sintilimab, Bevacizumab)

      Not yet recruiting
      • HCC
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Dec 20, 2020

      Neoadjuvant Chemo, Locally Advanced Cervical Cancer, Radical Hysterectomy Trial in Beijing (drug, diagnostic test, procedure,

      Recruiting
      • Neoadjuvant Chemotherapy
      • +8 more
      • Two cycles of neoadjuvant chemotherapy
      • +6 more
      • Beijing, Beijing, China
        Lei Li
      Jun 19, 2019

      Melanoma, Adjuvant Therapy Trial in Stockholm (Interferon-alpha2b - 1 year, Interferon-alpha2b - 2 years)

      Completed
      • Melanoma
      • Adjuvant Therapy
      • Interferon-alpha2b - 1 year
      • Interferon-alpha2b - 2 years
      • Stockholm, Sweden
        Karolinska Institutet, Karolinska University Hospital,
      Dec 13, 2010